Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Hypothyroidism Drug Profiles and Clinical Trials Report - Global Trends and Analysis Review, H2 2017 - Research and Markets

Research and Markets
Posted on: 20 Nov 17

The "Hypothyroidism Drug Profiles and Clinical Trials - Global Trends and Analysis Review, H2 2017" report has been added to Research and Markets' offering.

Hypothyroidism clinical trials report provides comprehensive analysis and trends in global Hypothyroidism disease clinical trials. The research work analyzes the evolution of Hypothyroidism clinical trial trends across countries and regions.

The report focuses on drugs and therapies being evaluated for Hypothyroidism treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, phases, trial status and sponsor types.

Major drugs under development in Hypothyroidism are provided in the report along with their details of Mechanism of Action, Route of Administration, Target, therapy, molecule and class.

Scope of the Report:

  • Number of Hypothyroidism clinical trials across regions - Asia and Oceania, Europe, Middle East Africa and Americas
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Hypothyroidism
  • Both observational and interventional trials analyzed
  • Success rates of trials are analyzed
  • Trends in enrollment over the past ten years identified
  • Leading sponsors of Hypothyroidism clinical trials worldwide are listed

Types:

  • Primary hypothyroidism - caused by disease to thyroid gland itself and is the most common cause of hypothyroidism.
  • Secondary hypothyroidism - dysfunction of pituitary gland or hypothalamus

Drugs:

  • Levothyroxine (synthetic T4) is the most commonly prescribed drug

Companies Mentioned

  • AZIENDA OSPEDALIERO-UNIVERSITARIA DI PARMA
  • Azienda USL Modena
  • Bracco S.p.A.
  • GlaxoSmithKline
  • GlaxoSmithKline Pharmaceuticals Ltd
  • IBSA Institut Biochimique SA
  • Ipe, LLC
  • Shri Karthikeya Pharma
  • Takeda Pharmaceutical Company Ltd
  • UNI-PHARMA SA

For more information about this report visit https://www.researchandmarkets.com/research/4pk74h/hypothyroidism

View source version on businesswire.com: http://www.businesswire.com/news/home/20171120005992/en/

Business Wire
www.businesswire.com

Last updated on: 20/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.